WHO ICTRP trial
Clinical study on the effect of anti-VEGF therapy combined with compound Danshen…
ChiCTR2400084849 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400084849 |
|---|---|
| Public title | Clinical study on the effect of anti-VEGF therapy combined with compound Danshen dripping pills on diabetic macular edema and retinal microcirculation in patients with type 2 diabetes mellitus |
| Scientific title | Clinical study on the effect of anti-VEGF therapy combined with compound Danshen dripping pills on diabetic macular edema and retinal microcirculation in patients with type 2 diabetes mellitus |
| Primary sponsor | Xi 'an People's Hospital (Xi 'an Fourth Hospital) |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 1 |
| Countries | China |
| Conditions | Diabetic retinopathy |
| Interventions | experimental group:Zaltrap Injection Combined with Compound Danshen Dropping Pills for oral administration;control group:Zaltrap Injection |
| Registration date | May 27, 2024 |
| Target size | experimental group:45;control group:45 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: